On Tuesday, Novartis AG ADR (NYSE: NVS) was -0.10% drop from the session before settling in for the closing price of $98.45. A 52-week range for NVS has been $92.35 – $120.92.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 0.78% over the last five years. When this article was written, the company’s average yearly earnings per share was at 17.15%. With a float of $1.96 billion, this company’s outstanding shares have now reached $2.00 billion.
The firm has a total of 76057 workers. Let’s measure their productivity. In terms of profitability, gross margin is 74.43%, operating margin of 27.93%, and the pretax margin is 25.89%.
Novartis AG ADR (NVS) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Novartis AG ADR stocks. The insider ownership of Novartis AG ADR is 0.00%, while institutional ownership is 6.77%. The most recent insider transaction that took place on Aug 12 ’24, was worth 733,572.
Novartis AG ADR (NVS) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of 1.83 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 17.15% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 6.65% during the next five years compared to 5.63% growth over the previous five years of trading.
Novartis AG ADR (NYSE: NVS) Trading Performance Indicators
You can see what Novartis AG ADR (NVS) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 0.90. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.96. Likewise, its price to free cash flow for the trailing twelve months is 13.04.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 8.57, a number that is poised to hit 1.82 in the next quarter and is forecasted to reach 8.22 in one year’s time.
Technical Analysis of Novartis AG ADR (NVS)
Analysing the last 5-days average volume posted by the [Novartis AG ADR, NVS], we can find that recorded value of 1.02 million was lower than the volume posted last year of 1.32 million. As of the previous 9 days, the stock’s Stochastic %D was 48.77%. Additionally, its Average True Range was 1.27.
During the past 100 days, Novartis AG ADR’s (NVS) raw stochastic average was set at 9.20%, which indicates a significant decrease from 32.72% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 15.33% in the past 14 days, which was lower than the 16.04% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $105.72, while its 200-day Moving Average is $106.39. Now, the first resistance to watch is $98.64. This is followed by the second major resistance level at $98.93. The third major resistance level sits at $99.42. If the price goes on to break the first support level at $97.86, it is likely to go to the next support level at $97.38. Should the price break the second support level, the third support level stands at $97.09.
Novartis AG ADR (NYSE: NVS) Key Stats
There are 2,044,000K outstanding shares of the company, which has a market capitalization of 192.42 billion. As of now, sales total 46,660 M while income totals 14,850 M. Its latest quarter income was 13,172 M while its last quarter net income were 3,189 M.
